BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17416007)

  • 1. [Ginsenosides and dexamethasone in managing the liver injury and renal function after transcatheter arterial chemoembolization for hepatic carcinoma patient].
    Feng YL; Ling CQ; Chen Z; Li B; Gu W
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):844-7. PubMed ID: 17416007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization.
    Yinglu F; Changquan L; Xiaofeng Z; Bai L; Dezeng Z; Zhe C
    J Altern Complement Med; 2009 Feb; 15(2):175-81. PubMed ID: 19216654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: a randomized, controlled and double-blinded prospective trial].
    Feng YL; Ling CQ; Zhu DZ; Yu CQ; Chen Z; Li B
    Zhong Xi Yi Jie He Xue Bao; 2005 Mar; 3(2):99-102. PubMed ID: 15763053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
    Liu MZ; Wang XS; Cai L; Gu MF; Liu H; Li Q; Cui NJ; Zhang YQ; Li GH; Li JQ
    Ai Zheng; 2005 Jan; 24(1):82-6. PubMed ID: 15642207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
    Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on integrative medicine for preventing and treating post-transcatheter arterial chemoembolization].
    Feng YL; Ling CQ; Li B
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jun; 25(6):534-6. PubMed ID: 16025970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma].
    Liang SN; Liu LL; Su HY; Feng B; Zhao GS; Xu K
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):790-2. PubMed ID: 19173817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of therapeutic effects between transcatheter arterial chemoembolization and transcatheter arterial-portal venous double chemoembolization in treatment of moderate and advanced stages of primary liver carcinoma].
    Wu YP; Zhang WZ; Li L; Guo RP; Xie CM; Cai PQ
    Ai Zheng; 2003 Aug; 22(8):880-3. PubMed ID: 12917041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
    Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy].
    Zhang HJ; Yang JJ; Wang WX; Jiang X; Mao YJ; Yang CA; Guo JX
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):907-10. PubMed ID: 18782532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM; Qin H; Wang CB; Fang XH; Ma QY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective effect of Yigan Fuzheng Paidu capsules combined with ozone on CCl4-induced acute hepatic injury in dogs].
    Li LJ; Yang YG; Wang C; Zhang ZL; Huo D; Hua HY; Chen PC; Zhang HS; Guo YB
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):689-94. PubMed ID: 17545091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Doses of epirubicin used in oily chemoembolization of hepatocellular carcinoma].
    Nakamura H; Murakami T; Tomoda K; Nakanishi K; Hori S; Oi H; Tsukaguchi I; Watanabe H; Masuike M; Inoue Y
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2218-21. PubMed ID: 7944444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epirubicin in the treatment of malignant obstructive jaundice].
    Chen Y; Yan ZP; Wang JH; Wang XL; Cheng JM; Gong GQ; Liu QX; Qian S; Liu R; Luo JJ
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):397-9. PubMed ID: 17045011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
    Tzeng WS; Wu RH; Chang SC; Chou CK; Lin CY; Chen JJ; Yang SC; Lin CH
    J Vasc Interv Radiol; 2008 Mar; 19(3):342-50. PubMed ID: 18295692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
    Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
    Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization].
    Huang JH; Wu PH; Gu YK; Zhang FJ; Li CX; Gao F; Zhang L; Fan WJ; Li CJ
    Ai Zheng; 2006 Aug; 25(8):1003-6. PubMed ID: 16965683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial.
    Tian G; Liu J; Zhou JS; Chen W
    Anticancer Drugs; 2009 Jun; 20(5):389-95. PubMed ID: 19287305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.